Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Peldesine (BCX 34) dihydrochloride 是一种有效的,竞争性,可逆和口服活性的嘌呤核苷磷酸化酶 (PNP) 抑制剂,对人,大鼠和小鼠红细胞 (RBC)PNP 的 IC50分别为 36 nM,5 nM 和 32 nM。Peldesine dihydrochloride 还是一种 T 细胞 (T-cell) 增殖抑制剂,IC50为 800 nM。Peldesine dihydrochloride 可用于皮肤 T 细胞淋巴瘤,牛皮癣和 HIV 感染的研究。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
25 mg | ¥ 9,540 | 10-14周 | ||
50 mg | ¥ 12,397 | 10-14周 | ||
100 mg | ¥ 18,611 | 10-14周 |
Peldesine dihydrochloride 的其他形式现货产品:
产品描述 | Peldesine (BCX 34) dihydrochloride is a potent, competitive, reversible, and orally active inhibitor of purine nucleoside phosphorylase (PNP), exhibiting IC50 values of 36 nM, 5 nM, and 32 nM against human, rat, and mouse red blood cell (RBC) PNP, respectively. Additionally, it acts as an inhibitor of T-cell proliferation with an IC50 of 800 nM. This compound shows promise for research into cutaneous T-cell lymphoma, psoriasis, and HIV infection [1] [2] [3] [4]. |
体外活性 | Peldesine (BCX 34; 0-50 μM; 72 hours; Jurkat cells) could inhibit the T-cell proliferation completely at a concentration of less than 10 μM, in the presence of dGuo (10 μM). In contrast, the B-cell proliferation is not affected by Peldesine [1]. Peldesine (BCX 34) suppresses T-cell immune reaction in an IL-2-independent manner, and this means that Peldesine might affect a late phase rather than an early stage in T-cell activation [1]. Peldesine also, in the presence but not in the absence of deoxyguanosine, inhibits human leukemia CCRF-CEM T-cell proliferation with an IC 50 of 0.57 μM but not rat or mouse T-cell proliferation up to 30 μM [3]. Cell Viability Assay [1] Cell Line: Jurkat cells Concentration: 0-50 μM Incubation Time: 72 hours Result: In the presence of 10 μM dCuo, had a complete inhibitory effect for T-cell lines. |
分子量 | 314.17 |
分子式 | C12H13Cl2N5O |
CAS No. | 2772702-10-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Peldesine dihydrochloride 2772702-10-8 Inhibitor inhibitor inhibit